For laboratory research use only. This page summarises published scientific literature on ACE-031 in plain English, in a neutral research style. It is not medical advice and contains no guidance on doses, administration or human use.
Introduction
ACE-031 represents a unique category of research molecule: a soluble fusion protein rather than a traditional peptide. This comprehensive guide explores ACE-031’s mechanism, research applications, clinical history, and practical considerations for laboratory use. All information is presented for educational and research purposes only.
What is ACE-031?
ACE-031 is an ActRIIB-Fc fusion protein—a soluble form of activin receptor type IIB fused to the Fc portion of human immunoglobulin G (IgG). Unlike traditional peptides, ACE-031 is a recombinant protein produced through cell-based expression systems. This molecular distinction is crucial for understanding its properties and applications in research.
The fusion protein design allows ACE-031 to function as a “trap” or “decoy” receptor, binding and sequestering myostatin and activin-A in circulation, preventing them from interacting with native muscle receptors.
How ACE-031 Works: Mechanism of Action
ACE-031 operates through a fundamentally different mechanism than growth-factor-based approaches. Rather than stimulating muscle growth directly, it works through removal of growth inhibition:
- Myostatin Binding: ACE-031 binds with high affinity to myostatin, a negative regulator of muscle mass
- Sequestration: By binding myostatin, ACE-031 prevents it from activating the activin type IIB receptor on muscle cells
- Disinhibition: This removal of inhibitory signalling allows muscle cells to increase protein synthesis and growth
- Activin Inhibition: ACE-031 also neutralises activin-A, which contributes to muscle wasting in disease states
This mechanism is particularly effective in disease contexts where myostatin and activin signalling is pathologically elevated.
ACE-031 vs Traditional Peptides: A Crucial Distinction
It’s important to emphasise that ACE-031 is not a peptide in the traditional sense. Key differences include:
- Molecular Weight: ~80 kDa (much larger than peptides, which are typically <10 kDa)
- Production: Made via mammalian cell expression systems, not chemical synthesis
- Stability: Generally more stable than peptides; longer serum half-life (hours to days)
- Immunogenicity: Contains Fc region, which can modulate immune response
ACE-031 in Muscle Wasting Disease Research
The primary research focus for ACE-031 has been muscle wasting diseases. Two clinical trial programmes stand out:
Duchenne Muscular Dystrophy (DMD)
- Muscle strength metrics
- Functional mobility measures
- Reduction in muscle damage markers
- Slowing of disease progression
Bone Density and ACE-031 Research
Beyond muscle, emerging research explores ACE-031’s effects on bone metabolism. Myostatin signalling affects bone density through multiple pathways. By inhibiting myostatin, ACE-031 may:
- Enhance osteoblast activity
- Improve bone mineral density
- Support fracture healing
- Potentially address osteoporosis in disease states
This area remains relatively unexplored but represents an important research frontier.
ACE-031 vs Follistatin: Comparative Research Profiles
Both ACE-031 and Follistatin inhibit myostatin and activin signalling, but through different mechanisms and with different characteristics:
| Property | ACE-031 | Follistatin |
|---|---|---|
| Molecular Type | Fusion protein (80 kDa) | Peptide (37-44 kDa) |
| Target Specificity | Myostatin, Activin-A | Multiple TGF-β ligands |
| Half-Life | Days (Fc-mediated) | Hours |
| Systemic Effects | Sustained | More transient |
| Production | Mammalian cells | Chemical/bio synthesis |
ACE-031’s extended half-life and selective targeting make it particularly suited for chronic disease models, whilst Follistatin’s broader specificity may be preferred for certain research applications.
ACE-031 vs Myostatin Antibodies
Myostatin-specific antibodies represent another mechanistic approach to myostatin inhibition. Unlike ACE-031’s soluble receptor strategy:
- Antibodies: Directly bind myostatin protein itself
- ACE-031: Acts as decoy receptor, competing with native receptors
- Antibodies: May have different immunogenicity profiles
- ACE-031: Incorporates Fc region, leveraging existing immunoglobulin mechanisms
Both approaches prove effective in preclinical and clinical research; selection depends on specific research objectives.
UK Legal Status
ACE-031 remains unscheduled in the UK for legitimate research purposes. It may be legally purchased and used by licensed research organisations and qualified researchers conducting approved studies. Institutional oversight and regulatory compliance are essential.
UK Sourcing Considerations
When sourcing ACE-031 from UK-based suppliers, prioritise:
- Certificate of analysis with protein quantification and purity assessment
- Endotoxin testing results (<0.1 EU/mL typical for research grade)
- Sterility testing documentation
- Potency assays (receptor binding or functional assays)
- Proper cold chain delivery with temperature monitoring
- Clear research-use-only designation
Protein molecules require higher quality standards than peptides; ensure your supplier meets these requirements.
Conclusion
Ready to source ACE-031 for your research? PeptidesLab UK supplies premium-grade research proteins with full analytical documentation and proper cold chain handling. Explore our ACE-031 collection today.
Limits of the evidence
Published findings come from specific study designs, often in cell systems or animals, and do not transfer automatically to other settings. A paper about a molecule is not proof that any particular batch has a given biological effect. Purity data show what is in a vial; they do not show sterility, safety or suitability for any use outside the laboratory.
Laboratory handling
- Store lyophilised powder sealed, cold (−20 °C for long-term storage), dry and protected from light.
- Let vials reach room temperature before opening to limit condensation.
- Prepare solutions with suitable laboratory solvents and calibrated equipment, and label each with lot number, concentration and date.
- Split solutions into single-use aliquots and avoid repeated freeze–thaw cycles.
- Use the peptide calculator for concentration arithmetic (mg/mL).
For laboratory research use only. ACE-031 sold by Peptides Lab UK is supplied strictly for in vitro laboratory research. It is not for human or veterinary use, and nothing on this page is medical advice or guidance on administration. UK purchasers are responsible for complying with all applicable legislation.
